These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 1506153

  • 1. Efficacy of gadoteridol for contrast-enhanced magnetic resonance imaging in children.
    Ball WS, Parker JR, Davis PC, Glasier CM, Morris MR.
    Invest Radiol; 1992 Aug; 27 Suppl 1():S45-52. PubMed ID: 1506153
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of gadoteridol for magnetic resonance imaging of the brain and spine.
    Runge VM, Bronen RA, Davis KR.
    Invest Radiol; 1992 Aug; 27 Suppl 1():S22-32. PubMed ID: 1506150
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of gadoteridol for magnetic resonance imaging of extracranial head and neck pathology.
    Zoarski GH, Parker JR, Lufkin RB, Harnsberger HR, Rhoda CH.
    Invest Radiol; 1992 Aug; 27 Suppl 1():S53-7. PubMed ID: 1506154
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Phase II clinical trial of gadoteridol injection, a low-osmolal magnetic resonance imaging contrast agent.
    Carvlin MJ, De Simone DN, Meeks MJ.
    Invest Radiol; 1992 Aug; 27 Suppl 1():S16-21. PubMed ID: 1506148
    [Abstract] [Full Text] [Related]

  • 7. Phase III multicenter clinical investigation to determine the safety and efficacy of gadoteridol in children suspected of having neurologic disease.
    Ball WS, Nadel SN, Zimmerman RA, Byrd SE, Dietrich RB, Prenger EC, Drayer BP, Nelson MD, Morgan FW, Altman NR.
    Radiology; 1993 Mar; 186(3):769-74. PubMed ID: 8430186
    [Abstract] [Full Text] [Related]

  • 8. Clinical safety and efficacy of gadoteridol: a study in 411 patients with suspected intracranial and spinal disease.
    Runge VM, Bradley WG, Brant-Zawadzki MN, Carvlin MJ, DeSimone DN, Dean BL, Dillon WP, Drayer BP, Flanders AE, Harms SE.
    Radiology; 1991 Dec; 181(3):701-9. PubMed ID: 1947085
    [Abstract] [Full Text] [Related]

  • 9. Magnetic resonance imaging contrast agents.
    Runge VM.
    Curr Opin Radiol; 1992 Feb; 4(1):3-12. PubMed ID: 1739599
    [Abstract] [Full Text] [Related]

  • 10. Safety and diagnostic efficacy of gadoteridol for magnetic resonance imaging of the brain and spine in children 2 years of age and younger.
    Shah CC, Spampinato MV, Parmar HA, Raslan OA, Tomà P, Lin DDM, Vymazal J, Colosimo C, Enterline DS.
    Pediatr Radiol; 2021 Sep; 51(10):1895-1906. PubMed ID: 33950270
    [Abstract] [Full Text] [Related]

  • 11. [Use of Omniscan (gadodiamide) in magnetic resonance studies of the central nervous system (results of a multicenter study)].
    Sinitsyn VE, Kornienko VN, Nikitin VG, Pronin IN, Ternovoĭ SK, Tiutin LA, Iakobson MG.
    Vestn Rentgenol Radiol; 1995 Sep; (4):5-11. PubMed ID: 8571538
    [Abstract] [Full Text] [Related]

  • 12. Patterns of contrast enhancement in the pediatric spine at MR imaging with single- and triple-dose gadolinium.
    Tam JK, Bradley WG, Goergen SK, Chen DY, Pema PJ, Dubin MD, Teresi LM, Jordan JE.
    Radiology; 1996 Jan; 198(1):273-8. PubMed ID: 8539393
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Magnetic resonance imaging of the central nervous system in children with a new nonionic gadolinium contrast agent--gadoteridol injection (ProHance).
    Byrd SE, Darling CF, Wilczynski MA.
    J Natl Med Assoc; 1993 May; 85(5):361-6. PubMed ID: 8496990
    [Abstract] [Full Text] [Related]

  • 15. Review of the use of high-dose gadoteridol in the magnetic resonance evaluation of central nervous system tumors.
    Yuh WT, Fisher DJ, Mayr-Yuh NA, Tali ET, Nguyen HD, Gao F, Ehrhardt JC.
    Invest Radiol; 1992 Aug; 27 Suppl 1():S39-44. PubMed ID: 1506152
    [No Abstract] [Full Text] [Related]

  • 16. The use of MR contrast in neoplastic disease of the brain.
    Muroff LR, Runge VM.
    Top Magn Reson Imaging; 1995 Aug; 7(3):137-57. PubMed ID: 7654393
    [Abstract] [Full Text] [Related]

  • 17. Phase III multicenter trial of high-dose gadoteridol in MR evaluation of brain metastases.
    Yuh WT, Fisher DJ, Runge VM, Atlas SW, Harms SE, Maravilla KR, Mayr NA, Mollman JE, Price AC.
    AJNR Am J Neuroradiol; 1994 Jun; 15(6):1037-51. PubMed ID: 8073972
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy evaluation of gadoteridol for MR angiography of intracranial vascular lesions.
    McLachlan SJ, Francisco JC, Pernicone JR, Hasso AN.
    J Magn Reson Imaging; 1994 Jun; 4(3):405-11. PubMed ID: 8061440
    [Abstract] [Full Text] [Related]

  • 20. Midfield and low-field magnetic resonance imaging of the spine.
    Rothschild PA, Winkler ML, Grönemeyer DH, Kaufman L, D'Amour P.
    Top Magn Reson Imaging; 1988 Dec; 1(1):11-23. PubMed ID: 3078534
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.